DSM-Firmenich company profile

DSFIR · Euronext Amsterdam · EUR

Compare DSM-Firmenich
€103.60Change from previous close: −0.53%Absolute change: −€0.55

Close · November 17, 2026

Company profile

DSM-Firmenich has 20,786 employees and is headquartered in Kaiseraugst, Switzerland.

DSM-Firmenich AG operates through three segments: Perfumery & Beauty, which creates scents from natural, synthetic and biotech ingredients; Taste, Texture & Health, which supplies flavors, natural extracts, food enzymes, hydrocolloids, cultures, natural colorants and plant-based proteins to food and beverage makers; and Health, Nutrition & Care, which offers vitamins, nutritional lipids, probiotics and prebiotics, active pharmaceutical ingredients and biomedical solutions to dietary supplement, pharmaceutical, early life and medical nutrition markets. The company sells in Switzerland, the Netherlands, the rest of Europe, the Middle East and Africa, North America, Latin America, China and the rest of Asia.

In the fiscal year ended December 2025, revenue was 9.0 billion euros, down 0.2% from the previous year, and the company recorded a net loss of 1.1 billion euros. It employed 20,786 people. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

Company facts

Sector
Consumer
Industry
Specialty Chemicals
Headquarters
Wurmisweg 576, 4303, Kaiseraugst
Employees
20,786
Chief executive
Dimitri de Vreeze
Founded
1902
Fiscal year
January - December
Listing
DSFIR · Euronext Amsterdam
Indices
AEX
Currency
EUR
ISIN
CH1216478797

DSM-Firmenich and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DSM-FirmenichDSFIRNetherlands$27.97B20,7866.8%—
NovozymesNSIS.BDenmark$30.93B10,93323.4%41.4
EMS-CHEMIE HOLDINGEMSNSwitzerland$23.83B2,61729.9%42.3
SikaSIKASwitzerland$36.15B33,70013.6%29.2
GivaudanGIVNSwitzerland$44.74B17,50817.9%39.6
SymriseSY1Germany$14.31B12,93612.6%53.6

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare DSM-Firmenich with its competitors